Market Overview

UPDATE: Jefferies & Company Reiterates Buy Rating, Raises PT on ICON plc

Related ICLR
Healthways, Genesis Physicians Group Unite to Enhance Healthcare - Analyst Blog
PAREXEL's ClinPhone RTSM Cuts Clinical Trial Start-Up Time - Analyst Blog

In a report published Wednesday, Jefferies & Company reiterated its Buy rating on ICON plc (NASDAQ: ICLR), and raised its price target from $29.00 to $32.00.

Jefferies noted, “ICON's investor day focused on the competitive differentiation and margin leverage that should come from recent technology and informatics investments. With robust backlog growth, management's revenue outlook for 2013 appears conservative. Nonetheless, efficiency improvements, utilization, and centralized support should drive considerable margin improvement, likely to the 10%+ level before 2013 is over.”

ICON plc closed on Tuesday at $27.66.

Latest Ratings for ICLR

DateFirmActionFromTo
Oct 2014ISI GroupDowngradesStrong BuyNeutral
Aug 2014Credit SuisseMaintainsOutperform
Jul 2014BarclaysMaintainsOverweight

View More Analyst Ratings for ICLR
View the Latest Analyst Ratings

Posted-In: Jefferies & CompanyAnalyst Color Price Target Analyst Ratings

 

Related Articles (ICLR)

Around the Web, We're Loving...

Get Benzinga's Newsletters